Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Julia Frede, Ph.D.

Concepts (65)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Receptors, CXCR4120217370.620 Why?
Neoplastic Stem Cells3202113900.500 Why?
Autocrine Communication120131880.490 Why?
Aquaporins120131750.480 Why?
Esophageal Neoplasms3201615250.460 Why?
Multiple Myeloma4202248440.450 Why?
Neoplasms, Glandular and Epithelial120144990.400 Why?
Epithelium1201417740.390 Why?
Drug Resistance, Neoplasm3202152650.360 Why?
Cell Transformation, Neoplastic2201630530.360 Why?
Cell Division1201649060.350 Why?
Ion Channels1201311030.350 Why?
Transcription, Genetic1202181300.320 Why?
Immunotherapy1202137930.310 Why?
Cell Lineage4202126760.280 Why?
Stem Cells2201436120.250 Why?
Cell Differentiation22016118330.220 Why?
Cell Proliferation22016109900.210 Why?
Antineoplastic Agents22021138980.200 Why?
Galectins120212380.180 Why?
Immune Evasion120213370.170 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma120213710.170 Why?
Gene Expression Regulation, Leukemic120216650.170 Why?
Ovarian Neoplasms1201346480.160 Why?
Mutation52021288480.150 Why?
Clone Cells2201417760.130 Why?
Gene Regulatory Networks1202117210.120 Why?
Gene Expression Regulation, Neoplastic3202188950.120 Why?
Drug Resistance, Multiple120132700.120 Why?
Single-Cell Analysis1202120480.110 Why?
Molecular Targeted Therapy1202128840.090 Why?
Esophagus1201410280.090 Why?
Cell Line, Tumor22021172510.090 Why?
Mice, Transgenic22016100940.080 Why?
Melanoma1202155050.060 Why?
Epigenesis, Genetic1201433370.050 Why?
Animals520161708490.050 Why?
Humans920226866630.040 Why?
Aged, 80 and over12021593310.040 Why?
Treatment Failure1202226970.040 Why?
Paris12014410.040 Why?
Tumor Cells, Cultured1202168350.030 Why?
Xenograft Model Antitumor Assays1202138810.030 Why?
Aged220211622710.030 Why?
Proto-Oncogene Proteins B-raf1202118850.030 Why?
Female320213754590.030 Why?
Middle Aged220212164680.030 Why?
Receptors, Notch120147540.020 Why?
Follow-Up Studies22021397370.020 Why?
Male220213524650.020 Why?
Sequence Analysis, DNA1201850440.020 Why?
Protein Kinase Inhibitors1202152520.020 Why?
Neoplasm Recurrence, Local1202186100.020 Why?
Prognosis12021289230.010 Why?
Case-Control Studies12018216840.010 Why?
Infant12021339180.010 Why?
Nuclear Proteins1201460090.010 Why?
Child, Preschool12021411590.010 Why?
Young Adult12021560520.010 Why?
Transcription Factors12014119100.010 Why?
Child12021713610.010 Why?
Adolescent12021849570.010 Why?
Time Factors12014422710.010 Why?
Mice12014808030.010 Why?
Adult120212114000.000 Why?
Frede's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.